UroMems Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 75

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $60M

  • Investors
  • 14

UroMems General Information

Description

Developer of a smart implantable medical device designed to treat stress urinary incontinence in men and women. The company offers a smart implant system that utilizes mechatronics, embedded systems, and MEMS technology to automatically adapt to patient needs, enabling patients and healthcare providers to manage stress urinary incontinence through an automated implantable device.

Contact Information

Website
www.uromems.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5 Rue Raymond Chanas
  • 38320 Eybens
  • France
+33 04
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 5 Rue Raymond Chanas
  • 38320 Eybens
  • France
+33 04

UroMems Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

UroMems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series D) 13-May-2026 $60M Completed Generating Revenue
7. Accelerator/Incubator Completed Generating Revenue
6. Later Stage VC (Series C) 21-May-2024 Completed Generating Revenue
5. Grant 01-Jul-2023 Completed Generating Revenue
4. Secondary Transaction - Private Completed Generating Revenue
3. Later Stage VC (Series B) 06-Apr-2021 Completed Generating Revenue
2. Later Stage VC (Series A) 15-Nov-2016 $15.3M $15.3M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view UroMems’s complete valuation and funding history, request access »

UroMems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view UroMems’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

UroMems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a smart implantable medical device designed to treat stress urinary incontinence in men and women. The comp
Therapeutic Devices
Eybens, France
75 As of 2026

Zug, Switzerland
 

Bothell, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

UroMems Competitors (10)

One of UroMems’s 10 competitors is Implantica, a Corporation company based in Zug, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Implantica Corporation Zug, Switzerland
Verathon Formerly PE-Backed Bothell, WA
Urologix Formerly VC-backed Minneapolis, MN
Smart Medical Systems Venture Capital-Backed Ra'anana, Israel
Axonics Formerly VC-backed Irvine, CA
You’re viewing 5 of 10 competitors. Get the full list »

UroMems Patents

UroMems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026175875-A1 Method for determining a pressure offset, correction method, and implantable medical device Pending 21-Feb-2025
FR-3172430-A1 Method for determining pressure shift, method for correction, and implantable medical device Pending 21-Feb-2025
AU-2023283016-A1 Implantable medical device Pending 09-Jun-2022
EP-4536151-A1 Implantable medical device Pending 09-Jun-2022
FR-3136365-A1 Implantable medical device Active 09-Jun-2022 A61F2/004
To view UroMems’s complete patent history, request access »

UroMems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

UroMems Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ajax Health PE/Buyout Minority
Crédit Mutuel Equity Growth/Expansion Minority
Crédit Mutuel Innovation Venture Capital Minority
European Innovation Council Accelerator/Incubator Minority
Horizon 2020 Government
You’re viewing 5 of 14 investors. Get the full list »

UroMems FAQs

  • When was UroMems founded?

    UroMems was founded in 2011.

  • Where is UroMems headquartered?

    UroMems is headquartered in Eybens, France.

  • What is the size of UroMems?

    UroMems has 75 total employees.

  • What industry is UroMems in?

    UroMems’s primary industry is Therapeutic Devices.

  • Is UroMems a private or public company?

    UroMems is a Private company.

  • What is UroMems’s current revenue?

    The current revenue for UroMems is .

  • How much funding has UroMems raised over time?

    UroMems has raised $149M.

  • Who are UroMems’s investors?

    Ajax Health, Crédit Mutuel Equity, Crédit Mutuel Innovation, European Innovation Council, and Horizon 2020 are 5 of 14 investors who have invested in UroMems.

  • Who are UroMems’s competitors?

    Implantica, Verathon, Urologix, Smart Medical Systems, and Axonics are some of the 10 competitors of UroMems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process